Solomon Partners Hires Ko Kobayashi To Its Healthcare Team
CIOREVIEW >> Healthcare >>

Solomon Partners Hires Ko Kobayashi To Its Healthcare Team

By CIOReview | Tuesday, August 2, 2022

At all phases of the transaction process, Ko Kobayashi's strong cross-assignment counseling skills will be critical as they continue to develop into new healthcare sub-verticals.

FREMONT, CA: "Ko brings a unique perspective and added capabilities to our fast-growing healthcare practice. His exceptional cross-assignment advisory skills will be key as we continue to expand into new healthcare sub-verticals at all stages of the transaction process." says Marc Cooper, CEO of Solomon Partners.

Ko Kobayashi has joined Solomon Partners as a Managing Director in the Global Healthcare Group, a renowned financial advisory firm and independently operated affiliate of Natixis. Mr. Kobayashi formerly worked as an Executive Director in the Healthcare Group at Moelis & Company, where he executed Mergers & Acquisitions. Mr. Ko has over 16 years of experience advising public and private companies, primarily healthcare. He has experience in many strategic transactions, such as buy- and sell-side M&A, leveraged buyouts, divestitures, restructurings, equity, debt capital raises, and strategic board advisory assignments.

Mr. Kobayashi formerly worked at UBS Investment Bank as an Associate Director in the Financial Sponsors & Leveraged Finance Group. He possesses an MBA from the University of Pennsylvania's Wharton School of Business and a BS in Business Administration from Georgetown University.

"Im thrilled to be joining Solomon Partners Healthcare Group. The healthcare industry is constantly evolving, and I am excited to be part of a growing team with significant momentum and further the groups deep industry knowledge and execution experience to provide strategic solutions to our clients." says Mr. Kobayashi.

Over the last few years, a corporate emphasis has been strengthening and enhancing the firm's healthcare expertise. Solomons' healthcare investment banking unit has made significant progress in increasing the firm's presence in this industry. The Solomon Partners healthcare team was named the exclusive financial advisor to Prime Therapeutics on its proposed $1.35 billion acquisition of Magellan Health's pharmacy company, Magellan Rx Management.